Figure 2.

Percentages of patients infected with PIP-TAZ R isolates or with PIP-TAZ S isolates who were receiving appropriate antibiotic therapy (defined as at least 1 agent to which the infecting organism was susceptible) ≤ 24 h and ≤ 48 h after samples were obtained for culture.